Understanding iDose® TR: A Breakthrough in Glaucoma Treatment thumbnail

Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

Published Nov 16, 24
1 min read


iDose® TR marks a significant breakthrough in the treatment of glaucoma, providing a sustained and effective solution for managing intraocular pressure (IOP). In contrast to traditional eye drops that need to be applied every day, iDose® TR is a compact, implantable device crafted to provide a controlled release of medication directly into the eye over an prolonged period. This innovative approach eliminates the need for frequent dosing, dramatically boosting patient adherence and overall treatment effectiveness.

At Eye Center South, we are proud to offer iDose® TR as part of our comprehensive glaucoma care. The device is placed during a simple and low-risk procedure, focused on your comfort and ease. Once in place, it ensures a steady dose of the prescribed medication, keeping IOP levels consistent and ensuring your visual health. Patients who have difficulty managing the challenges of daily eye drop regimens can find relief from this state-of-the-art treatment.



Visit for more info At Eye Center South